Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by The University of Texas Health Science Center, Houston.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
The University of Texas Health Science Center, Houston
Information provided by:
The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00846690
First received: February 18, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The project is a study comparing the effectiveness of two topical anesthetics for control of pain associated with dental needle insertion in the palatal mucosa. A standard dental topical anesthetic (20% benzocaine) will serve as an "active" control and will be compared to a combination topical anesthetic, consisting of 20% lidocaine, 4% tetracaine and 2% phenylephrine (TAC Alternate Gel, Compounding Arts Pharmacy, Lafayette, LA).
Condition | Intervention | Phase |
---|---|---|
Dental Pain Postoperative Pain |
Drug: benzocaine Drug: TAC alternate gel |
Phase 4 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver) Primary Purpose: Treatment |
Official Title: | Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel for Control of Pain of Dental Needle Insertion in the Palate |
Resource links provided by NLM:
Drug Information available for:
Triamcinolone diacetate
Triamcinolone acetonide
Benzocaine
Triamcinolone
Triamcinolone hexacetonide
Hydroxypropyl cellulose
U.S. FDA Resources
Further study details as provided by The University of Texas Health Science Center, Houston:
Primary Outcome Measures:
- visual analogue scale score [ Time Frame: pre-op, insertion, every minute post-op for 10 minutes ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- blood pressure [ Time Frame: three times pre-op, insertion, ten times post-op ] [ Designated as safety issue: Yes ]
- oxygen saturation [ Time Frame: three times pre-op, insertion, ten times post-op ] [ Designated as safety issue: Yes ]
- heart rate [ Time Frame: three times pre-op, insertion, ten times post-op ] [ Designated as safety issue: Yes ]
Estimated Enrollment: | 20 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | May 2009 |
Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Active Comparator: Benzocaine
serves as "active" control
|
Drug: benzocaine
20% benzocaine., topical placement onto site, minimal amount, for 1 minute
Other Name: Hurricaine
|
Experimental: TAC
serves as comparator
|
Drug: TAC alternate gel
use 1 pump, place topically onto site, leave for 1-3 minutes
Other Name: 20% TAC alternate gel
|
Eligibility
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Volunteers 18 years or older
- Ability to consent to participate in the research
- Ability to communicate a VAS score
- Generally healthy, ASA I and ASA II
- No known drug allergies
- Ability to tolerate pulse oximeter and blood pressure cuff without psychological, or physiological consequence
Exclusion Criteria:
- Allergy or other contraindications to the topical anesthetics
- Inability to consent to participation in the study
- Use of analgesics prior to the procedure
- Vulnerable populations
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00846690
Contacts
Contact: Femme L Ambrosio, DDS | 858 603-6345 | femme.l.ambrosio@uth.tmc.edu |
Contact: Arthur H Jeske, DDS, PhD | 713 500 4506 | arthur.h.jeske@uth.tmc.edu |
Locations
United States, Texas | |
UT Pediatric Dentistry Clinic Houston Medical Center | Recruiting |
6655 Travis Suite 460, Texas, United States, 77030 | |
Contact: Femme L Ambrosio, DDS 858-603-6345 femme.l.ambrosio@uth.tmc.edu | |
Contact: Arthur H Jeske, DDS PhD 7135004506 arthur.h.jeske@uth.tmc.edu | |
Sub-Investigator: Robert Tate, DDS MS |
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
Investigators
Principal Investigator: | Femme L Ambrosio, DDS | UT Health Science Center Houston |
Study Chair: | Arthur H Jeske, DDS, PhD | UT Health Science Center Houston |
More Information
No publications provided
Keywords provided by The University of Texas Health Science Center, Houston:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 26, 2012
No publications provided
Responsible Party: | Femme Ambrosio, University of Texas Health Science Center Houston |
ClinicalTrials.gov Identifier: | NCT00846690 History of Changes |
Other Study ID Numbers: | HSC-DB-08-0484 |
Study First Received: | February 18, 2009 |
Last Updated: | February 18, 2009 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by The University of Texas Health Science Center, Houston:
topical anesthetics topical anesthesia 20% benzocaine |
TAC alternate gel combination topical anesthetics dental anesthesia |
Additional relevant MeSH terms:
Pain, Postoperative Toothache Postoperative Complications Pathologic Processes Pain Signs and Symptoms Tooth Diseases Stomatognathic Diseases Facial Pain Benzocaine |
Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on September 26, 2012